4453 Total Publications
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Tijms, BM, Gobom, J, Teunissen, C, Dobricic, V, Tsolaki, M, Verhey, F, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleó, A, Molinuévo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Bertram, L, Lovestone, S, Streffer, J, Vos, S, Adni, Blennow, K, Scheltens, P, Zetterberg, H and Visser, PJ
PMID: 8396164
; 2021; vol. 3;
Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease
Tommasi, NS, Gonzalez, C, Briggs, D, Properzi, MJ, Gatchel, JR and Marshall, GA
2021; Journal Int J Geriatr Psychiatry;
Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an F-18-AV-45 study
Wang, M, Yan, ZZ, Zhang, HW, Lu, JY, Li, L, Yu, JT, Wang, J, Matsuda, H, Zuo, CT, Jiang, JH and Alzheimer's Dis Neuroimaging, I
2021; Journal Quantitative Imaging in Medicine and Surgery; vol. 11; no. 1;
Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease
Khan, AF, Adewale, Q, Baumeister, TR, Carbonell, F, Zilles, K, Palomero-Gallagher, N and Iturria-Medina, Y
2021; Journal Brain;
Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals
Lussier, FZ, Benedet, AL, Therriault, J, Pascoal, TA, Tissot, C, Chamoun, M, Mathotaarachchi, S, Savard, M, Ashton, NJ and Karikari, TK
2021; Journal Brain Communications; vol. 3; no. 2; pp. fcab073;
Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data
Nader, CA, Ayache, N, Frisoni, GB, Robert, P, Lorenzi, M and Initiative, AsDN
2021; Journal Brain Communications;
Alzheimer's Disease-Related Metabolic Pattern in Diverse Forms of Neurodegenerative Diseases
Lau, A, Beheshti, I, Modirrousta, M, Kolesar, TA, Goertzen, AL and Ko, JH
2021; Journal Diagnostics (Basel); vol. 11; no. 11;
Conductance-Based Structural Brain Connectivity in Aging and Dementia
Frau-Pascual, A, Augustinack, J, Varadarajan, D, Yendiki, A, Salat, DH, Fischl, B, Aganj, I and Alzheimers Dis Neuroimaging, I
2021; Journal Brain Connectivity; vol. 11; no. 7; pp. 566-583;
Comparing Pathological Risk Factors for Dementia between Cognitively Normal Japanese and Americans
Cui, CD, Higashiyama, A, Lopresti, BJ, Ihara, M, Aizenstein, HJ, Watanabe, M, Chang, YF, Kakuta, C, Yu, ZM, Mathis, CA, Kokubo, Y, Fukuda, T, Villemagne, VL, Klunk, WE, Lopez, OL, Kuller, LH, Miyamoto, Y and Sekikawa, A
2021; Journal Brain Sciences; vol. 11; no. 9; pp. 11;
Inflammation, Negative Affect, and Amyloid Burden in Alzheimer’s Disease: Insights from the Kynurenine Pathway
Willette, AA, Pappas, C, Hoth, N, Wang, Q, Klinedinst, B, Willette, SA, Larsen, B, Pollpeter, A, Li, T and Le, S
2021; Journal Brain, behavior, and immunity;
